MILWAUKEE, July 28, 2017 /PRNewswire/ -- TRICAST, a leading provider of pharmacy benefit oversight and analytics solutions, is pleased to announce the recent additions of Jim Clair and Chris Lagnese, R.Ph. to the company's executive team as CEO and Vice President of Sales and Services, respectively. Jim is focused on the company's overall strategy and enhancing its services delivery to each TRICAST client. Chris is focused on TRICAST's sales as well as account management.
Jim was the CEO of Goold Health Systems, a leader in providing pharmacy benefits services in the Medicaid fee-for-service space, during a time of significant growth. Goold was acquired by Change Healthcare in 2013, after which Jim served as President of that wholly-owned subsidiary until July 2016.
"I'm really excited to be working at TRICAST. All of health care, but especially pharmacy is at an inflection point, where consumers need the right prescription at the right time from the right provider at the right price for the right reason. TRICAST is uniquely qualified to help health plans, PBM's, the middle market, etc. ensure that their pharmacy benefit is most clinically and cost-effective. The team at TRICAST is top-notch, our REVEAL Software-as-a-Service (SaaS) product is a game-changer, and we're very fortunate to be working with very forward-thinking clients already."
Chris was the Director of PBA Products & Services at Change Healthcare. He worked closely with clients and product development teams to drive solutions which resulted significant growth of a very profitable pharmacy benefits administration portfolio. Chris was responsible for the retention and growth, including sales within a demanding marketplace.
"TRICAST is in a great position to fully capitalize on the convergence of deploying our forward-thinking products like REVEAL and services with the health care space's increasing need for compliance and auditing. I am excited to bring TRICAST's solutions to the marketplace to not only meet current needs, but also support innovative approaches to help simplify the complexities of pharmacy benefit cost oversight and regulatory compliance going forward."